US Stocks
/
Tempest Therapeutics, Inc. Share Price
Tempest Therapeutics, Inc. Share Price

Tempest Therapeutics, Inc. Share Price

NASDAQ: TPST | Micro Cap
$0.92
+$0.92 (--%) Last updated on 08 Aug, 2026 | 01:12 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Tempest Therapeutics, Inc. Stock Performance

Open
$0.93
Prev. Close
N/A
Circuit Range
N/A
Day Range
$0.91 - $0.93
Year Range
$0.86 - $12.06
Volume
859
Average Traded
$0.92

Tempest Therapeutics, Inc. Share Price Chart

$0.91$0.93
L
Show Current Price
H

Tempest Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.80M
PE Ratio (TTM)
-0.14
Dividend Yield
N/A
EPS (TTM)
$-6.33
Revenue (TTM)
N/A
Return On Equity (TTM)
-393.85%
Profit Margin
N/A
Debt to Equity
0.50
Quarterly Earnings Growth YoY
66.74%

Tempest Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$7.90M-$9.57M-$10.56M-$10.86M-$7.87M-$3.51M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A-21.08%-10.30%-2.88%27.53%55.39%

Tempest Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars202220232025
RevenueN/AN/AN/A
Net Profit-$35.71M-$29.49M-$26.26M
Net Profit MarginN/AN/AN/A
Income ChangeN/A17.41%10.95%

About Tempest Therapeutics, Inc.

Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its clinical-stage lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc.

Tempest Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$0.88
$0.92
+5.78%
Jul 2026
$1.11
$0.86
-22.42%
Jun 2026
$1.52
$1.11
-27.60%
May 2026
$2.02
$1.54
-23.76%
Apr 2026
$1.65
$2.02
+24.69%
Mar 2026
$2.25
$1.62
-26.36%
Feb 2026
$2.47
$2.20
-19.56%
Jan 2026
$2.87
$2.73
-4.70%
Dec 2025
$3.20
$2.87
-10.31%
Nov 2025
$10.08
$3.20
-69.30%
Oct 2025
$10.25
$10.43
+2.71%
Sep 2025
$10.22
$10.15
+2.53%

TPST Share Price FAQs

What is Tempest Therapeutics, Inc. share price today?

chevron-up
Tempest Therapeutics, Inc. share price today is $0.92 as on August 8, 2026 at 1:12 am IST.

What is the 52 week high and 52 week low of Tempest Therapeutics, Inc. stock?

chevron-up
The 52 week high of Tempest Therapeutics, Inc. stock is $12.06, while the 52 week low is $0.86 as of 8 Aug '26.

What is TPST's market capitalisation today?

chevron-up
TPST market capitalisation is $3.80M as of August 10, 2026, at 5:36 am IST.

What is TPST's net income for the last quarter?

chevron-up
TPST's net income for the last quarter is -0.00B USD.

What is the 5 year returns of TPST?

chevron-up
The 5 year returns of TPST is -99.51% as on 8 Aug '26.

What is the high & low stock price of TPST today?

chevron-up
TPST stock price hit a high of $0.93 and low of $0.91 as of 8 Aug '26.

Can I buy TPST shares in India?

chevron-up
Yes. You can buy TPST in India by opening an international trading account.